This site is intended for healthcare professionals only
LoginRegister

NPPA sets retail prices for 41 drugs, including 29 Fixed-Dose Combinations containing Empagliflozin or Sitagliptin

Written By : Ruchika Sharma |Medically Reviewed By : Dr. Kamal Kant Kohli   |  
NPPA sets retail prices for 41 drugs, including 29 Fixed-Dose Combinations containing Empagliflozin or Sitagliptin
  • whatsapp
  • Telegram

New Delhi: In its 133rd meeting held on May 29, 2025, the National Pharmaceutical Pricing Authority (NPPA) has fixed retail prices for 41 drug formulations under the Drugs (Prices Control) Order, 2013.

Among these, 29 of these formulations are anti-diabetic fixed-dose combinations (FDCs) involving the widely prescribed agents Empagliflozin and Sitagliptin. These include:

. 18 Empagliflozin-based combinations, with prices ranging from Rs 9.90 to Rs 33.13 per tablet.

. 11 Sitagliptin-based combinations (with Glimepiride and Metformin), all priced between Rs 12.82 and Rs 14.50 per tablet.

The price control move targets widely prescribed anti-diabetic fixed-dose combinations, manufactured and marketed by companies including Zydus Healthcare, USV, Emcure Pharma, Alkem Labs, Glenmark Pharma, and Torrent Pharma.

Apart from anti-diabetic combinations, NPPA also fixed retail prices for several other essential formulations, including Atorvastatin & Ezetimibe tablets for dyslipidemia, Ceftriaxone, Sulbactam & Disodium Edetate Powder for solution for Infusion for bacterial infections, Cholecalciferol oral drops for vitamin D deficiency, Melatonin & Zolpidem Tartrate tablets for sleep disorders, and Alginate Raft-Forming Oral Suspension for acid reflux. The move aims to ensure affordability of essential therapies across diverse therapeutic areas including cardiovascular, gastrointestinal, infectious diseases, and respiratory care. The retail prices are exclusive of GST.

Sl. No.

Medicines

Strength

Unit

Manufacturer & Marketing Company

Retail Price (Rs.)

(1)

(2)

(3)

(4)

(5)

(6)

1

Alginate Raft- Forming Oral Suspension

Each 5 ml contains:

Sodium Alginate IP 250 mg

Sodium Bicarbonate IP 133.5 mg

Calcium Carbonate IP 80 mg

1 ml

M/s Akums Drugs & Pharmaceuticals Ltd./ M/s Apex Laboratories Pvt. Ltd.

0.93

2

Atorvastatin & Ezetimibe Tablets

Each film coated tablet contains:

Atorvastatin Calcium IP equivalent to Atorvastatin 10mg

Ezetimibe IP 10mg

1 Tablet

M/s Safetab Life Science/ M/s Ajanta Pharma Ltd.

19.66

3

Atorvastatin & Ezetimibe Tablets

Each film coated tablet contains:

Atorvastatin Calcium IP equivalent to Atorvastatin 80 mg

Ezetimibe IP 10mg

1 Tablet

M/s Windlas Biotech Ltd./ M/s Zydus Healthcare Ltd.

54.29

4

Ceftriaxone, Sulbactam & Disodium Edetate Powder for solution for Infusion

Each vial contains:

Ceftriaxone Sodium IP eq. to Ceftriaxone 1000 mg

Disodium Edetate IP 37 mg

Sulbactam Sodium IP eq. Sulbactam 500 mg

1 vial

M/s BDR Pharma- ceuticals International Pvt. Ltd./ M/S Glenmark Pharma-ceuticals Ltd.

515.57

5

Cefuroxime & Potassium Clavulanate Tablets

Each film coated tablet contains:

Cefuroxime Axetil IP eq. to Cefuroxime 500 mg

Potassium Clavulanate Diluted IP eq. to Clavulanic Acid 125 mg

1 Tablet

M/s Supermax Drugs & Pharmaceuticals Pvt. Ltd./ M/s Profic Organic Ltd.

60.62

6

Cholecalciferol Oral Drops

Each ml of Suspension contains:

Vitamin D3 IP 800 IU

1 ml

M/s Stedman Pharmaceuticals Pvt. Ltd.

4.76

7

Clindamycin & Nicotinamide gel

Clindamycin Phosphate IP eq. to Clindamycin 1.00% w/w Nicotinamide IP 4.00% w/w

1 gm

M/s Skymap Pharmaceuticals Pvt. Ltd./ M/s German Remedies Pharmaceuticals Pvt. Ltd.

7.24

8

Iron, Folic Acid & Cyanocobalamin Syrup

Each 5 ml contains:

Ferric Ammonium Citrate IP 110 mg

Folic Acid IP 1.5 mg

Cyanocobalamin IP 15 mcg

Sorbitol (70%) (Non- Crystallising)

1 ml

M/s East African (I) Overseas / M/s Mankind Prime Labs Pvt. Ltd.

0.23

9

Melatonin & Zolpidem Tartrate Tablets

Each film coated tablet contains:

Melatonin BP 3 mg

Zolpidem Tartrate IP 5 mg

1 Tablet

M/s Windlas Biotech Ltd./

M/s Ipca Laboratories Ltd.

6.62

10

Melatonin & Zolpidem Tartrate Tablets

Each film coated tablet contains:

Melatonin BP 3 mg

Zolpidem Tartrate IP 10 mg

1 Tablet

M/s Windlas Biotech Ltd./

M/s Ipca Laboratories Ltd.

8.73

11

Polmacoxib & Paracetamol Tablets

Each uncoated tablet contains:

Polmacoxib IH 2 mg

Paracetamol IP 325 mg

1 Tablet

M/s Hetero Labs Ltd./ M/s Zuventus Healthcare Ltd.

15.39

12

Empagliflozin & Metformin Hydrochloride (ER) Tablets

Each film coated bilayered tablet contains:

Empagliflozin 10mg

Metformin Hydrochloride 1000mg (as extended release)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Blue Cross Laboratories Pvt. Ltd.

9.90

13

Empagliflozin & Metformin Hydrochloride Tablets

Each film coated tablet contains:

Empagliflozin 12.5 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Unison Pharmaceuticals Pvt. Ltd.

18.10

14

Empagliflozin & Metformin Hydrochloride Tablets

Each film coated tablet contains:

Empagliflozin 12.5 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/

M/s Zydus Healthcare Ltd.

18.10

15

Empagliflozin & Metformin Hydrochloride Tablets

Each film coated tablet contains:

Empagliflozin 12.5 mg

Metformin Hydrochloride IP 1000 mg

1 Tablet

M/s Unison Pharmaceuticals Pvt. Ltd.

19.01

16

Empagliflozin & Metformin Hydrochloride (ER) Tablets

Each film coated tablet contains:

Empagliflozin 12.5 mg

Metformin Hydrochloride IP 1000 mg (as Extended release)

1 Tablet

M/s MSN Laboratories Pvt. Ltd.

17.86

17

Empagliflozin & Metformin Hydrochloride (ER) Tablets

Each film coated bilayered tablet contains:

Empagliflozin 25 mg

Metformin Hydrochloride IP 1000 mg (as extended release)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Blue Cross Laboratories Pvt. Ltd.

11.70

18

Empagliflozin & Metformin Hydrochloride (ER) Tablets

Each film coated tablet contains:

Empagliflozin 25 mg

Metformin Hydrochloride IP 1000 mg (as Extended release)

1 Tablet

M/s MSN Laboratories Pvt. Ltd.

18.75

19

Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated tablet contains:

Empagliflozin 10 mg

Linagliptin 5 mg

Metformin Hydrochloride IP 1000 mg (as Extended Release)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Zydus Healthcare Ltd.

29.08

20

Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated tablet contains:

Empagliflozin 10 mg,

Linagliptin 5 mg,

Metformin Hydrochloride IP 1000 mg (as Extended Release)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Cadila Pharmaceuticals Ltd.

29.08

21

Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated tablet contains:

Empagliflozin 10 mg,

Linagliptin 5 mg,

Metformin Hydrochloride IP 1000 mg (as Extended Release)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Glenmark Pharmaceuticals Ltd.

29.08

22

Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated tablet contains:

Empagliflozin 10 mg,

Linagliptin 5 mg,

Metformin Hydrochloride IP 1000 mg (as Extended Release)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Alkem Laboratories Ltd.

28.57

23

Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated tablet contains:

Empagliflozin 10 mg,

Linagliptin 5 mg,

Metformin Hydrochloride IP 1000 mg (as Extended Release)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Ltd.

17.50

24

Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated tablet contains:

Empagliflozin 25 mg,

Linagliptin 5 mg,

Metformin Hydrochloride IP 1000 mg (as Extended Release)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Zydus Healthcare Ltd.

33.13

25

Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated tablet contains:

Empagliflozin 25 mg,

Linagliptin 5 mg,

Metformin Hydrochloride IP 1000 mg (as Extended Release)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Cadila Pharmaceuticals Ltd.

32.43

26

Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated bilayer tablet contains:

Empagliflozin 25 mg,

Linagliptin 5 mg,

Metformin Hydrochloride IP 1000 mg (as Extended Release)

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Emcure Pharmaceuticals Ltd.

33.13

27

Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated tablet contains:

Empagliflozin 25 mg,

Linagliptin 5 mg,

Metformin Hydrochloride IP

1000 mg (as Extended Release)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Glenmark Pharmaceuticals Ltd.

33.13

28

Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated tablet contains:

Empagliflozin 25 mg,

Linagliptin 5 mg,

Metformin Hydrochloride IP 1000 mg (as Extended Release)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Alkem Laboratories Ltd.

30.36

29

Empagliflozin, Linagliptin & Metformin Hydrochloride (ER) Tablets

Each film coated tablet contains:

Empagliflozin 25 mg,

Linagliptin 5 mg,

Metformin Hydrochloride IP 1000 mg (as Extended Release)

1 Tablet

M/s Pure and Cure Healthcare Pvt. Ltd./ M/s Torrent Pharmaceuticals Ltd.

19.50

30

Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg

Glimepiride IP 1 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/

M/s USV Private Ltd.

12.82

31

Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg

Glimepiride IP 1 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Emcure Pharmaceuticals Ltd.

12.82

32

Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg

Glimepiride IP 1 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/

M/s Alkem Laboratories Ltd.

12.82

33

Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg

Glimepiride IP 1 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Dr. Reddys Laboratories Ltd.

12.82

34

Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg

Glimepiride IP 1 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/

M/s Zydus Healthcare Ltd.

12.82

35

Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg

Glimepiride IP 2 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/

M/s USV Private Ltd.

14.50

36

Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg

Glimepiride IP 2 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Emcure Pharmaceuticals Ltd.

14.50

37

Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg

Glimepiride IP 2 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/

M/s Alkem Laboratories Ltd.

14.50

38

Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg

Glimepiride IP 2 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/

M/s Eris Lifesciences Ltd.

14.50

39

Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg

Glimepiride IP 2 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/ M/s Dr. Reddys Laboratories Ltd.

14.50

40

Sitagliptin, Glimepiride & Metformin Hydrochloride Tablets

Each film coated tablet contains:

Sitagliptin Phosphate Monohydrate IP eq. to Sitagliptin 50 mg

Glimepiride IP 2 mg

Metformin Hydrochloride IP 500 mg

1 Tablet

M/s Exemed Pharmaceuticals/

M/s Zydus Healthcare Ltd.

14.50

41

Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup

Each 5 ml contains:

Phenylephrine Hydrochloride IP 5 mg

Chlorpheniramine Maleate IP 2 mg

1 ml

M/s Vapi Care Pharma Pvt. Ltd. /

M/s Apex Laboratories Pvt. Ltd.

1.01

Note:

(a) The manufacturer of above-mentioned formulations i.e., “new drug” under paragraph 2(1)(u) of the DPCO, 2013 shall fix the retail price as specified in column (6) of the table hereinabove.
(b) The manufacturer may add Goods and Services Tax only if they have paid actually or it is payable to the Government on the retail price mentioned in column (6) of the above said table.
(c) The retail price for a pack of the aforesaid formulation shall be arrived at by the concerned manufacturer in accordance with the retail price specified in column (6) of the above table as per provisions contained in paragraph 11 of the DPCO, 2013. The manufacturer shall issue a price list in Form–V from date of Notification as per paragraph 24 of the DPCO, 2013 to NPPA through IPDMS and submit a copy to State Drug Controller and dealers.
(d) As per para 24(4) of DPCO 2013, every retailer and dealer shall display price list and the supplementary price list, if any, as furnished by the manufacturer, on a conspicuous part of the premises where he carries on business in a manner so as to be easily accessible to any person wishing to consult the same.
(e) The above mentioned retail price is applicable only to the individual manufacturer / marketer as mentioned above i.e. who have applied for the same by submitting Form-I for price fixation / revision as stipulated under DPCO, 2013 and subject to fulfilment of all the applicable statutory requirements as laid down by the Govt. under relevant statutes/ rules, including manufacturing license permission from the Competent Authority i.e. the Central/State Licensing Authority, as may be applicable, by the concerned manufacturer/marketing companies.
(f) In case the retail price of any of the aforesaid formulations is not complied with, as per instant price notification and notes specified hereinabove, then the concerned manufacturer/marketing company shall be liable to deposit the overcharged amount along with the interest thereon under the provisions of the DPCO, 2013 read with the Essential Commodities Act, 1955.
(g) Consequent to the fixation of retail price of such formulation as specified in column (2) of the above table with the strength and name of Manufacturer & Marketing Companies specified in the corresponding entries in Column (3) & (5) thereof, the price order(s) fixing the retail price of the formulation with specified strength for that Manufacturer & Marketing Companies as specified in corresponding entries in Column (2), (3) and (5) thereof, if any, issued prior to this notification, stand(s) superseded.

For complete product-wise details, refer to official notification.


NPPAempagliflozinsitagliptinglimepiridemetforminzydus HealthcareUSVemcure pharmaalkem labsglenmark pharmatorrent pharmaparacetamollinagliptin
Ruchika Sharma
Ruchika Sharma

    Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

    Dr. Kamal Kant Kohli
    Dr. Kamal Kant Kohli

    Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751

    Show Full Article
    Next Story
    X